Brand-Name Drugs Increasing at 10X Cost of Inflation, McCaskill Report Finds

(Source – www.hsgac.senate.gov)

WASHINGTON – U.S. Senator Claire McCaskill, the top-ranking Democrat on the Senate Homeland Security and Governmental Affairs Committee, today released a report as part of her years-long effort to investigate dramatic prescription drug price increases, showing that the prices of many of the most popular brand-name drugs increased at nearly ten times the cost of inflation from 2012 to 2017. Continue reading press release here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.